Logo image of LBNK.CA

LITHIUMBANK RESOURCES CORP (LBNK.CA) Stock Fundamental Analysis

TSX-V:LBNK - TSX Venture Exchange - CA53681T1012 - Common Stock - Currency: CAD

0.265  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LBNK. LBNK was compared to 799 industry peers in the Metals & Mining industry. LBNK has a great financial health rating, but its profitability evaluates not so good. LBNK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LBNK had negative earnings in the past year.
In the past year LBNK has reported a negative cash flow from operations.
LBNK had negative earnings in each of the past 5 years.
LBNK had a negative operating cash flow in each of the past 5 years.
LBNK.CA Yearly Net Income VS EBIT VS OCF VS FCFLBNK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

LBNK's Return On Assets of -36.90% is in line compared to the rest of the industry. LBNK outperforms 41.30% of its industry peers.
With a Return On Equity value of -44.63%, LBNK perfoms like the industry average, outperforming 44.93% of the companies in the same industry.
Industry RankSector Rank
ROA -36.9%
ROE -44.63%
ROIC N/A
ROA(3y)-47.38%
ROA(5y)-44.39%
ROE(3y)-66.18%
ROE(5y)-56.39%
ROIC(3y)N/A
ROIC(5y)N/A
LBNK.CA Yearly ROA, ROE, ROICLBNK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LBNK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LBNK.CA Yearly Profit, Operating, Gross MarginsLBNK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

LBNK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LBNK has been reduced compared to a year ago.
LBNK.CA Yearly Shares OutstandingLBNK.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
LBNK.CA Yearly Total Debt VS Total AssetsLBNK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -1.40, we must say that LBNK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.40, LBNK perfoms like the industry average, outperforming 40.93% of the companies in the same industry.
LBNK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.4
ROIC/WACCN/A
WACCN/A
LBNK.CA Yearly LT Debt VS Equity VS FCFLBNK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

2.3 Liquidity

A Current Ratio of 2.72 indicates that LBNK has no problem at all paying its short term obligations.
LBNK has a Current ratio of 2.72. This is in the better half of the industry: LBNK outperforms 61.58% of its industry peers.
A Quick Ratio of 2.72 indicates that LBNK has no problem at all paying its short term obligations.
LBNK's Quick ratio of 2.72 is fine compared to the rest of the industry. LBNK outperforms 63.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.72
LBNK.CA Yearly Current Assets VS Current LiabilitesLBNK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

LBNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.99%, which is quite impressive.
EPS 1Y (TTM)36.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-177.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LBNK.CA Yearly EPS VS EstimatesLBNK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LBNK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LBNK.CA Price Earnings VS Forward Price EarningsLBNK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LBNK.CA Per share dataLBNK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LBNK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LITHIUMBANK RESOURCES CORP

TSX-V:LBNK (4/25/2025, 7:00:00 PM)

0.265

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-03 2025-02-03
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners12.67%
Ins Owner ChangeN/A
Market Cap13.22M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 2
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS0.21
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.9%
ROE -44.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.38%
ROA(5y)-44.39%
ROE(3y)-66.18%
ROE(5y)-56.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3167.43%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.72
Altman-Z -1.4
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-177.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-277.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-240.84%
OCF growth 3YN/A
OCF growth 5YN/A